Form D — NRX Pharmaceuticals, Inc.
0001437749-25-006621 · filed 2025-03-07
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $3,500,000
- Total sold
- $3,500,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- NRX Pharmaceuticals, Inc.
- CIK
- 1719406
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1201 ORANGE STREET
WILMINGTON, DE 19801 - Phone
- 484-254-6134
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jonathan Javitt · Executive OfficerWilmington, DE Find on LinkedIn ↗
-
Michael Abrams · Executive OfficerWilmington, DE Find on LinkedIn ↗
-
Patrick Flynn · DirectorWilmington, DE Find on LinkedIn ↗
-
Chaim Hurvitz · DirectorWilmington, DE Find on LinkedIn ↗
-
Dennis McBride · DirectorWilmington, DE Find on LinkedIn ↗
-
Michael Taylor · DirectorWilmington, DE Find on LinkedIn ↗
View original on SEC EDGAR.